– USA, CA – Vibrato Medical, an innovator in the treatment of peripheral arterial disease, today announced the appointment of Paul LaViolette to its board of directors.
“Paul has helped bring forward so many ground-breaking and life-changing innovations. The contributions he has made to the medical technology industry have left a profound impact,” said CEO, Juliana Elstad. “Paul knows firsthand the challenges medical technology innovators face, and his deep understanding of healthcare and experience guiding companies of varying sizes will provide the Vibrato board with valuable insights as we look to grow our company and create a new therapy. We’re very excited to have him join Vibrato.”
Paul LaViolette will join current board members Dr. Bobby Azamian, Juliana Elstad, Dr. Babak Nazer, and Jason Tester.
About Paul A. LaViolette
Paul LaViolette has over 40 years of global medical technology management experience and is currently a Managing Partner and COO at SV Health Investors, a venture and growth equity investor in healthcare.
Paul LaViolette has a long history in MedTech, including his time as COO at Boston Scientific Corporation, a $10-billion-revenue medical device leader. During LaViolette’s 15 years at BSC, he served as COO, Group President, Cardiovascular, Group President, EndoSurgery, President-Cardiology, and President-International. While there, he played an integral role in innovation, from integrating two dozen acquisitions to leading extensive product development programs. This experience led him to his current role with SVHI, which he joined in 2009 as a Venture Partner and in 2011 was made a Partner. LaViolette was promoted to Managing Partner in 2014 and heads the firm’s medical device investments.
“I believe the role of entrepreneurial innovation in healthcare and MedTech is critical. I’m so pleased to be joining the Vibrato board and to support development of this disruptive, noninvasive therapy for advanced peripheral arterial disease,” commented LaViolette. “I look forward to helping the Vibrato team as it sets out to deliver a clinical and economic benefit to this significant patient population.”
About Vibrato Medical
Vibrato Medical is a private company located in Irvine, California. The company has developed the first wearable therapeutic ultrasound device for the noninvasive, outpatient treatment of peripheral arterial disease. It is designed to promote vasodilation, collateral vessel growth, and angiogenesis, and restore perfusion. Its leadership team brings deep experience in developing and commercializing medical devices and is supported by an experienced board of directors as well as recognized clinical leaders in the field of PAD. Vibrato Medical’s mission is to be the preferred therapeutic system for patients with reduced tissue perfusion.
For more information: https://www.vibratomedical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
